Pharmaceuticals
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody
* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...
2019-08-21 21:35
4518
NeuroVive Pharmaceutical AB Interim Report January - June 2019
STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...
2019-08-21 15:24
7841
CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting
SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...
2019-08-20 10:18
5954
China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019
TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...
2019-08-19 20:00
10688
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress
SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...
2019-08-19 13:50
6107
CSPC Pharmaceutical Announces 2019 Interim Results
Profit Attributable To Shareholders Increased 24.8% to RMB1,878 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Investment Increased Significantly HONG KONG, Aug. 19, 2019 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group")...
2019-08-19 12:20
4664
Global market of dietary supplement is welcoming a rising star GLYMATE
BREA, California, Aug. 16, 2019 /PRNewswire/ -- Glymate™, a newly founded nutraceutical company inSouthern California. Its proprietary sugar balance dietary supplement was officially announced inthe United States in June 2019, marking the official launch of the global marketing of this product, w...
2019-08-16 21:00
3116
Xinhua Silk Road: Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise
BEIJING, Aug. 16, 2019 /PRNewswire/ -- Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent years. Tasly ...
2019-08-16 10:56
3165
China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results
HAIKOU, China, Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...
2019-08-15 18:30
8069
CStone Pharmaceuticals Reports First Half 2019 Financial Results
SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and molecularly-targeted drugs for the treatment of cancer, today released its recent business ...
2019-08-15 15:31
5964
China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results
HANGZHOU, China, Aug. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider inChina, today announced i...
2019-08-14 21:00
7500
CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study
SUZHOU, China, Aug. 13, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient inChina for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of t...
2019-08-13 12:21
6883
China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate
TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced to...
2019-08-12 20:00
7058
Ascletis Opens Clinical Development Shanghai Center
HANGZHOU and SHAOXING, China, Aug. 12, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today the opening of it...
2019-08-12 18:00
2462
EnGeneIC Wins Innovation Award from Australian Financial Review
Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targe...
2019-08-09 12:49
1870
Cancer Research UK and Hummingbird Bioscience Join Forces to Advance Novel Antibody Drug Into Clinical Trials
SINGAPORE, Aug. 8, 2019 /PRNewswire/ -- Cancer Research UK, the world's leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have today (Thursday) announced a partnership to develop Hummingbird's anti-HER3 antibody drug, HMBD-001, for th...
2019-08-08 07:01
2811
Chad Finney Joins Pilatus Comparator Solutions as VP, North America
WATFORD, England, Aug. 7, 2019 /PRNewswire/ -- Pilatus Comparator Solutions are delighted to announce further expansion of its global team with the appointment ofChad Finney to the position of Vice President North America. Chad brings with him a wealth of experience in Clinical Trials Supply and ...
2019-08-07 19:35
2384
CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park
SUZHOU, China, Aug. 7, 2019 /PRNewswire/ -- The signing ceremony for CStone Pharmaceuticals' ("CStone") (HKEX: 2616) Global R&D Headquarters and Industrialization Base ("the Project") took place in Suzhouon August 6. The event marks the building of yet another state-of-the-art research and devel...
2019-08-07 14:47
7650
New Test Capable of Detecting Clinically Significant Prostate Cancer in Small Blood Sample
* International research team unveils new, pain-free approach to avoid up to 7 in 10 unnecessary prostate biopsies * Simple blood test to boost performance of traditional PSA screening BANGKOK andBASEL, Switzerland, Aug. 6, 2019 /PRNewswire/ -- An international research team at Mahidol Univer...
2019-08-06 16:44
1996
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
SUZHOU, China, Aug. 6, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced the signing of a collaboration agreement with Shenogen Pharma Group Ltd. ("Shenogen") to ...
2019-08-06 08:00
3434
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 316 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 309 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 295 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14849
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10421
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9809
